期刊文献+

微小RNA在宫颈癌的早期筛查中的应用及预后价值研究 被引量:11

Application and Prognostic Value of Small RNA in Early Screening of Cervical Cancer
下载PDF
导出
摘要 目的研究微小RNA在宫颈癌的早期筛查中的应用及预后价值。方法采用实时定量PCR(定量PCR)测定宫颈癌肿瘤组织中miRNA的表达水平(miR-21,miR-27a,miR-34a,miR-155,miR-196a,miR-203)。结果 miR-27a在宫颈上皮内瘤变(CIN2-3)中的表达水平显著高于CIN1(P=0.023),而在鳞状细胞癌(SCC)中的表达水平高于CIN2-3(P=0.033)。此外,miR-34a在CIN2-3中的表达水平显著低于CIN1(P=0.041),在SCC中的表达水平低于CIN2-3(P=0.021)。与CIN1比较,CIN2-3的miR-27a表达水平上调(P=0.028)而miR-34a表达水平下调,HPV16阳性与宫颈癌显著相关(CIN2-3/CIN1:P=0.027;SCC/CIN2-3:P=0.036)。miR-34a的表达水平与吸烟状况和HPV16相关。结论检测miRNA表达水平有助于评估不同宫颈癌变和预测HPV感染结果。 Objective To study the application and prognostic value of small RNA in early screening of cervical cancer.Methods Real-time quantitative PCR( quantitative PCR) was used to determine the expression levels of miRNA cervical cancer tissues( miR-21,miR-27 a,miR-34 a,miR-155,miR-196 a,miR-203). Results miR-27 a expression level in cervical intraepithelial neoplasia( CIN) 2-3 was significantly higher than CIN1( P = 0. 023),while the expression levels of squamous cell carcinoma( SCC) was higher than CIN2-3( P = 0. 033). In addition,miR-34 a expression level in CIN2-3 was significantly lower than CIN1( P = 0. 041),and in SCC was lower than CIN2-3( P = 0. 021). Compared with CIN1,miR-27 a expression of CIN2-3 increased( P = 0. 028) and miR-34 a decreased,HPV 16 positive expression was correlated with CIN( CIN2-3 /CIN1: P = 0. 027; SCC/CIN2-3: P = 0. 036). miR-34 a expression level and smoking status and HPV16 were correlated. Conclusion The detection of miRNA expression level can help evaluate cervical lesions and HPV infection.
出处 《实用癌症杂志》 2016年第6期883-885,共3页 The Practical Journal of Cancer
关键词 宫颈上皮内瘤 子宫颈癌 微RNA的表达 HPV感染 Cervical intraepithelial neoplasia(CIN) Cervical cancer Expression of micro RNA HPV infection
  • 相关文献

参考文献11

二级参考文献36

  • 1LiLiu,De-HuaWu,Yan-QingDing.Tiaml gene expression and its significance in colorectal carcinoma[J].World Journal of Gastroenterology,2005,11(5):705-707. 被引量:16
  • 2宗永生,吴秋良,林素暇,何洁华,张昌卿.EB病毒相关性疾病病理学研究的进展[J].中山大学学报(医学科学版),2005,26(5):481-487. 被引量:27
  • 3Tavassoli FA, Davilee P. WHO classification of tumor. Pathology & ge- netics tumors of the breast and female genital organs [M] Lyon : ARC Press ,2003:266.
  • 4Cox JT. Human papillomavirus testing in primary cervical screening and abnormal papanicolaou management[J]. Chstet Gyneeol Surv ,2006,61 (6) :15.
  • 5Park JY, Lee SM,Yoo CW,ct al . Risk factors predicting residual dis- ease in subsequent hysterectomy following conization for cervical intra- epithelial neoplasia (CIN) m and micro invasive cervical cancer [J]. Gynecol Onco1,2007,107 ( 1 ) :39.
  • 6Song SH, Lee JK, Oh MJ , et al. Persistent HPV infection after coniza- tion in patients with negativem argins[ J]. Gynecol Oncol,2006,101 (3) :418.
  • 7Bar -Am A, Gamzu R, Levin I , et al. Follow-up by combined cytology and human papillomavirus testing for patients post-cone biopsy : results of a long-term follow-up[ J]. Gynecol Oneo1,2003,91 ( 1 ) : 149 .
  • 8Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions in- volved in cancers[J]. Proc Natl Acad Sci U S A, 2004,101(9) : 2999 -3004.
  • 9Liu X, Sempere LF, Guo Y, et al. Involvement of microRNAs in lung cancer biology and therapy [ J ]. Transl Res, 2011,157 ( 4 ) : 200-208.
  • 10Taganov KD, Boldin MP, Chang KJ, et al. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses[J]. Proc Natl Acad Sci USA, 2006,103 (33) : 12481-12486.

共引文献80

同被引文献89

引证文献11

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部